Showing results (241-250 of 630) with videos related to
Sort By:
Pageof 63
Modern Rheumatology|November 21, 2013
Methotrexate in refractory bilateral juvenile temporal arteritis: Report of a caseCorrado Campochiaro, Barbara Guglielmi, Alvise Berti, et al.Clinical and Experimental Immunology|November 5, 2024
The B-cells paradigm in systemic sclerosis: an update on pathophysiology and B-cell-targeted therapiesCristina Scaletti, Sara Pratesi, Silvia Bellando Randone, et al.Retina (Philadelphia, Pa.)|January 5, 2002
Eye pain after vitreoretinal surgery: a prospective study of 185 patientsS Fekrat, S H Elsing, S C Raja, et al.Ophthalmology|February 4, 2012
Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trialJeffrey S Heier, Peter A Campochiaro, Linda Yau, et al.Nature Genetics|October 25, 2011
A rare penetrant mutation in CFH confers high risk of age-related macular degenerationSoumya Raychaudhuri, Oleg Iartchouk, Kimberly Chin, et al.The Journal of Physiology|March 7, 2001
Expression and permeation properties of the K(+) channel Kir7.1 in the retinal pigment epitheliumM Shimura, Y Yuan, J T Chang, et al.Diabetes|December 1, 1988
Aldose reductase expression in human diabetic retina and retinal pigment epitheliumS A Vinores, P A Campochiaro, E H Williams, et al.The British Journal of Ophthalmology|March 5, 1998
Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranesY S Chen, S F Hackett, C L Schoenfeld, et al.European Journal of Internal Medicine|January 2, 2021
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort studyEmanuel Della-Torre, Marco Lanzillotta, Corrado Campochiaro, et al.Journal of Scleroderma and Related Disorders|April 6, 2022
Patient-reported outcome instruments in clinical trials of systemic sclerosisJohn D Pauling, Joana Caetano, Corrado Campochiaro, et al.Pageof 63